Synergistic drug combination effectively blocks Ebola virus infection

Although a group of FDA-approved drugs were previously identified with activity against Ebola virus, most of them are not clinically useful because their human blood concentrations are not high enough to inhibit EBOV infection. We screened 795 unique three-drug combinations in an EBOV entry assay. T...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antiviral Res
Main Authors: Sun, Wei, He, Shihua, Martínez-Romero, Carles, Kouznetsova, Jennifer, Tawa, Gregory, Xu, Miao, Shinn, Paul, Fisher, Ethan, Long, Yan, Motabar, Omid, Yang, Shu, Sanderson, Philip E., Williamson, Peter R., García-Sastre, Adolfo, Qiu, Xiangguo, Zheng, Wei
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5182099/
https://ncbi.nlm.nih.gov/pubmed/27890675
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2016.11.017
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados